(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
0.00% $ 72.50
Live Chart Being Loaded With Signals
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer...
Stats | |
---|---|
Volumen de hoy | 100.00 |
Volumen promedio | 25.00 |
Capitalización de mercado | 64.80M |
EPS | $0 ( 2024-04-22 ) |
Last Dividend | $0.500 ( 2023-10-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 11.80 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2011-10-14 | Williams Frank E Jr | Sell | 0 | Bioqual |
INSIDER POWER |
---|
0.00 |
Last 1 transactions |
Buy: 0 | Sell: 0 |
Bioqual, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bioqual, Inc. Finanzas
Annual | 2022 |
Ingresos: | $62.66M |
Beneficio Bruto: | $8.64M (13.80 %) |
EPS: | $0.930 |
FY | 2022 |
Ingresos: | $62.66M |
Beneficio Bruto: | $8.64M (13.80 %) |
EPS: | $0.930 |
FY | 2018 |
Ingresos: | $35.88M |
Beneficio Bruto: | $8.73M (24.31 %) |
EPS: | $4.10 |
FY | 2017 |
Ingresos: | $36.60M |
Beneficio Bruto: | $9.90M (27.06 %) |
EPS: | $4.44 |
Financial Reports:
No articles found.
Bioqual, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$1.000 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.500 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0700 | 2004-09-02 |
Last Dividend | $0.500 | 2023-10-05 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-27 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | $7.96 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.75 | -- |
Div. Sustainability Score | 9.38 | |
Div.Growth Potential Score | 4.38 | |
Div. Directional Score | 6.88 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PHPPY | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
DSKYF | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
UMICY | Ex Dividend Junior | 2023-08-18 | Annually | 0 | 0.00% | |
JTEKF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
BMBN | Ex Dividend Knight | 2023-06-30 | Semi-Annually | 0 | 0.00% | |
RWCB | Ex Dividend Knight | 2023-07-28 | Quarterly | 0 | 0.00% | |
FBPA | Ex Dividend Junior | 2023-08-18 | Semi-Annually | 0 | 0.00% | |
WTKWY | Ex Dividend Knight | 2023-08-29 | Annually | 0 | 0.00% | |
LZRFY | Ex Dividend Junior | 2023-07-03 | Bi-Monthly | 0 | 0.00% | |
CIBN | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0152 | 1.500 | 9.70 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0163 | 1.200 | 9.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0249 | 1.500 | -0.834 | -1.251 | [0.1 - 1] |
payoutRatioTTM | 0.467 | -1.000 | 5.33 | -5.33 | [0 - 1] |
currentRatioTTM | 4.22 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.02 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.573 | 1.500 | 2.37 | 3.55 | [0.2 - 2] |
debtRatioTTM | 0.0600 | -1.500 | 9.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.20 | 2.00 | 6.60 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 8.87 | 2.00 | 5.57 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0910 | -1.500 | 9.64 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.141 | 1.000 | -0.978 | -0.978 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0145 | 1.000 | -1.711 | -1.711 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.58 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.068 | 0.800 | 6.21 | 4.97 | [0.5 - 2] |
Total Score | 9.38 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 67.76 | 1.000 | 3.26 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0249 | 2.50 | -0.536 | -1.251 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 8.87 | 2.00 | 7.04 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.690 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.20 | 2.00 | 6.60 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.467 | 1.500 | 5.33 | -5.33 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.145 | 1.000 | 8.87 | 0 | [0.1 - 0.5] |
Total Score | 4.38 |
Bioqual, Inc.
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico